Related Experiment Videos

Alcohol consumption and coronary heart disease: a causal and protective factor

Rachel S Eidelman1, Paul Vignola, Charles H Hennekens

  • 1Division of Cardiovascular Research Mount Sinai Medical Center, New York, NY 10001, USA. drseidlman@aol.com

Seminars in Vascular Medicine
|October 14, 2005
PubMed

Insights

Light to moderate alcohol consumption, defined as one to six drinks weekly, is linked to reduced risks of heart disease and death. Heavy drinking, however, significantly increases preventable mortality risks.

Area of Science:

  • Cardiovascular epidemiology
  • Preventive medicine
  • Alcohol research

Background:

  • Heavy alcohol consumption is a major cause of preventable deaths.
  • Light to moderate alcohol intake shows potential health benefits, including reduced coronary heart disease risk.
  • Benefits are observed across various alcoholic beverage types (wine, beer, liquor).

Purpose of the Study:

  • To summarize the cardiovascular and mortality outcomes associated with varying levels of alcohol consumption.
  • To differentiate the health impacts of light-to-moderate versus heavy alcohol intake.

Main Methods:

  • Review of epidemiological studies on alcohol consumption and health outcomes.
  • Analysis of data correlating alcohol intake levels with coronary heart disease, total mortality, and other specific conditions.

Main Results:

  • Light to moderate alcohol consumption (1-6 drinks/week) is associated with reduced risk of coronary heart disease and all-cause mortality in men and women.
  • Benefits extend to reduced risks of peripheral arterial disease, ischemic stroke, sudden cardiac death, and angina.
  • Even small alcohol amounts may increase blood pressure and certain cancer risks, notably breast cancer.

Conclusions:

  • The level of alcohol consumption critically influences health outcomes, distinguishing between life-saving and life-threatening effects.
  • Light to moderate drinking may offer cardiovascular protection, while heavy drinking poses significant mortality risks.
  • Further research is needed to fully understand the complex relationship between alcohol, cardiovascular health, and cancer risk.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...